110.00

Content Details
Information on this page was last modified on : 2021/05/11 7:04:03 PM

I-Menate tablet 50 mg 25×10’s

I-Menate tablet contains Dimenhydrinate | belongs to Monoethanol amine derivative

Alternate brands of I-Menate tablet 50 mg 25×10’s

Brand Name Price Savings
Ravinate Injection 50 mg 25 Ampx1 mL  102.35 You can save 7.65
Minate Injection 50 mg 25 Ampx1 mL  150.00 You will pay -40 more
Menhydrin Injection 50 mg 25 Ampx1 mL  172.50 You will pay -62.5 more
Lawrvinate Injection 50 mg 25 Ampx1 mL  90.00 You can save 20
I-Menate Liqd 12.5 mg/4 mL 60 mL  15.00 You can save 95
List of alternate brands

How it works

I-Menate tablet 50 mg 25×10’s works by acting on the vomiting center in the brain and on the inner ear to reduce the symptoms of motion sickness and vertigo.

Side effects

Major & minor side effects for I-Menate tablet 50 mg 25×10’s

  • Headache
  • Dry mouth
  • Difficulty with passing urine
  • Drowsiness
  • Fatigue
  • Rash
  • Constipation
  • Difficulty in falling asleep
  • Vision disturbances

Uses of I-Menate tablet 50 mg 25×10’s

What is it prescribed for?

  • Motion sickness

    This medicine is used in the treatment of motion sickness, a condition characterized by symptoms such as nausea, vomiting, dizziness, uneasiness, etc. which may be caused due to travel by air, car, boat, etc.

  • Vertigo and vestibular disorders

    This medicine is used in the treatment of vertigo and vestibular disorders, which may cause symptoms such as dizziness, headache, nausea, vomiting, hearing changes, visual disturbances, etc.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 15-30 minutes of oral administration of the dose.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 3 to 6 hours.

  • Safe with Alchohol?

    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as drowsiness and dizziness. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to I-Menate tablet 50 mg 25×10’s or any other inactive ingredients present along with this medicine.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

General Warnings
  • Hepatic impairment

    This medicine should be used with caution in patients with a history of liver diseases due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Driving or Operating machinery

    Use of this medicine may cause symptoms such as blurred vision, dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

  • Seizures

    This medicine should be used with caution in patients with a known history of seizure disorder due to the increased risk of recurrent seizures. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Prostatic hypertrophy

    This medicine should be used with caution in patients with prostatic hypertrophy due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Glaucoma

    This medicine should be used with caution in patients with glaucoma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Use in pediatrics

    This medicine is not recommended for use in patients less than 2 years of age since the safety and efficacy of use are not clinically established.

  • Renal impairment

    This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Dosage

  • Missed Dose

    This medicine is usually taken on an as-needed basis. If you are on a scheduled dosing regimen of this medicine, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Amitriptyline moderate
  • Amantadine moderate
  • Topiramate severe
  • Duloxetine moderate
  • Chlorpromazine moderate
  • Zonisamide severe
Disease interactions
  • moderate

    This medicine should be used with caution in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Report any symptoms such as an irregular heart rate, dizziness, fainting, uneasiness, shortness of breath, etc. to the doctor immediately. Close monitoring of vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with a known history of asthma or chronic obstructive pulmonary disease due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

General Instructions

Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. This medicine should be used with caution in patients less than 6 years of age and only under the supervision of your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information:

How to use I-Menate tablet 50 mg 25×10’s

For IM administration, each mL (50 mg) of solution is injected as needed. For IV administration, inject diluted solution over a period of 2 min.
Reconstitution: For IV administration, each mL (50 mg) of solution must be diluted in 10 mL of NaCl 0.9%.
Stability: Store at 20°C-25°C (68°F-77°F). Protect from light.

what are the adverse effects of I-Menate tablet 50 mg 25×10’s?

Urticaria, drug rash, dryness of mouth, nose and throat, drowsiness, restlessness, excitation, nervousness, insomnia, euphoria, anorexia, nausea, vomiting, diarrhoea, constipation, hypotension, blurred vision, diplopia, vertigo, tinnitus, palpitation, tachycardia, urinary frequency, difficult urination, urinary retention, auditory and visual hallucination (particularly when dosage recommendation are exceeded, cholestatic jaundice).

What happens if I miss a dose of I-Menate tablet 50 mg 25×10’s?

ORAL: Adults: 50-100 mg two or three times daily. Children: Under 1 yr, Not recommended; 1-6 yr, 12.5-25 mg; 7- 12 yr, 25-50 mg; both two or three times daily.
INJECTION: Adults: IM/IV. 50 mg every 4 hr, max 100 mg every 4 hr. Children: Above 1 yr, IM 1.25 mg/kg or 37.5 mg/square meter 4 times daily, max 300 mg/day.

One of the following licensed pharmacy from the nearest location will deliver I-Menate tablet 50 mg 25×10’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “I-Menate tablet 50 mg 25×10’s”
Shopping Cart